Parkinson’s Disease affects nearly everyone. We all know someone who is dealing with it as a patient, caregiver or friend or family member. Alarmingly, symptoms can show up at 50 years of age or sooner. Fortunately, there is great work being done to eradicate it and improve the lives of millions worldwide.
Recently, we made a prediction that PEMF will cure all cancers. It is really ambitious to think one device will do all that.
We believe that because PEMF seems to work on everything…
Like, it could almost reverse aging.
…and you know that is not possible because of how cells work.
Sometimes, cells just die and no one really knows the reason why.
Importantly, how cells work is also the reason we believe PEMF will treat things that haven’t been discovered yet.
For example: Parkinson’s Disease affects 1 million people in the US and 10 million worldwide. Parkinsons.org says the combined direct and indirect cost of Parkinson’s, including treatment, social security payments and lost income, is estimated to be nearly $52 billion per year in the United States alone.
According to the National Institutes for Health (NIH) “Parkinson’s disease occurs when nerve cells, or neurons, in an area of the brain that controls movement become impaired and/or die. Normally, these neurons produce an important brain chemical known as dopamine. When the neurons die or become impaired, they produce less dopamine, which causes the movement problems of Parkinson’s. Scientists still do not know what causes cells that produce dopamine to die.”
This is the good news:
In October 2008 the Food and Drug Administration approved the use of PEMF therapy for treatment of major depressive disorder in Parkinson’s Disease patients…
Researchers found the PEMF treatments resulted in a marked improvement in motor and non-motor symptoms such as mood swings, sleeplessness, pain and sexual and cognitive dysfunctions. Furthermore they suggested that PEMF therapy should be tested in large cohorts of Parkinson’s Disease patients as monotherapy and should also be considered as a treatment modality for newly diagnosed PD patients.
The word monotherapy is really important here. Specifically, it means scientists; doctors and researchers are suggesting PEMF is all that is needed to stop Parkinson’s in it’s tracks. Shockingly, this notion has not floated above all of the time and money spent on developing drug therapies for Parkinson’s. We are always concerned when PEMF therapies are approved and recommended and they are not seeing widespread use.
Most importantly, recommending PEMF as a monotherapy is extremely rare. Furthermore, this indicates PEMF may become the first choice for treating Parkinson’s disease.
You can read the full documents here: Read Now
Each time someone asks us about studies involving a certain disease or injury we seem to be able to find it. Sometimes they are locked or written in foreign languages but mostly PEMF literature is pretty easy to find.
Importantly, they always have good results and no side effects.
We would be completely dumbfounded if it turned out differently.
That is why we can be so confident with our predictions.
So, if you see something you think we might like please pass it along. We love to share stories about people’s successes with PEMF
Pocket Sized - Unique and Highly Advanced Features
Sedona Pro and Pro +
State of the art design, usability and professional performance